Latest stories on IMRN
Immuron Showcases Oral Antibody Platform in July 20 Investor Presentation
TipRanks56 · neutralproduct/pr
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
Business Insider50 · neutralgeneral
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar | IMRN Stock News
StockTitan55 · neutralproduct/pr
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
Business Insider63 · neutralearnings
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy | IMRN Stock News
StockTitan63 · neutralproduct/pr